Sharon Mates
Director · 2 filings · Latest: Apr 30, 2026
Benitec Biopharma Inc.
Seaport Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
— | Mates Sharon | — | Dec 5, 2024 | Proposed Sale | $84.02 | 51,697 | $4.3M | — | |
— | Mates Sharon | — | Dec 4, 2024 | Proposed Sale | $85.73 | 51,000 | $4.4M | — | |
— | Mates Sharon | — | Aug 30, 2024 | Proposed Sale | $72.78 | 34,396 | $2.5M | — | |
— | Mates Sharon | — | Aug 29, 2024 | Proposed Sale | $72.51 | 35,604 | $2.6M | — | |
— | Mates Sharon | — | Aug 28, 2024 | Proposed Sale | $72.69 | 32,699 | $2.4M | — | |
— | Mates Sharon | — | Aug 27, 2024 | Proposed Sale | $73.52 | 40,513 | $3.0M | — | |
— | Mates Sharon | — | Aug 26, 2024 | Proposed Sale | $74.53 | 22,713 | $1.7M | — | |
— | Mates Sharon | — | Aug 23, 2024 | Proposed Sale | $74.40 | 28,680 | $2.1M | — | |
— | Mates Sharon | — | Aug 22, 2024 | Proposed Sale | $74.62 | 39,380 | $2.9M | — |